S. 248, to allow an earlier start for state health care coverage innovation waivers under the Patient Protection and Affordable Care Act; to Health, Education, Labor, & Pensions.
S. 1410, to amend the Internal Revenue Code of 1986 to provide incentives for life sciences research. S. 1468, to amend title XVIII of the Social Security Act to improve access to diabetes self-management training by authorizing certified diabetes educators to provide diabetes self-management training services, including as part of telehealth services, under Part B of the Medicare program; to Finance.
S. 2113, to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health; to Health, Education, Labor, & Pensions.
S. 2119, to establish a pilot program to address overweight/obesity among children from birth to age five in child care settings and to encourage parental engagement; to Health, Education, Labor, & Pensions.
S. 2516, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars.
H.R. 2276, to require the director of the U.S. Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes; jointly to Judiciary and Energy & Commerce.
H.R. 2632, to amend the Internal Revenue Code of 1986 to provide incentives for life sciences research.
H.R. 2741, to amend title XVIII of the Social Security Act to reduce the occurrence of diabetes in Medicare beneficiaries by extending coverage under Medicare for medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing Type 2 diabetes; jointly to Energy & Commerce and Ways & Means.
H.R. 2787, to amend title XVIII of the Social Security Act to improve access to diabetes self-management training by authorizing certified diabetes educators to provide diabetes self-management training services, including as part of telehealth services, under Part B of the Medicare program; jointly to Energy & Commerce and Ways & Means.
H.R. 2799, to amend the Public Health Service Act to authorize grants to provide treatment for diabetes in minority communities; to Energy & Commerce.
H.R. 4604, to amend the Public Health Service Act to provide for a national program to conduct and support activities toward the goal of significantly reducing the number of cases of overweight and obesity among individuals in the United States.

S. 248, to allow an earlier start for state health care coverage innovation waivers under the Patient Protection and Affordable Care Act; to Health, Education, Labor, & Pensions. S. 1410, to amend the Internal Revenue Code of 1986 to provide incentives for life sciences research.
S. 1468, to amend title XVIII of the Social Security Act to improve access to diabetes self-management training by authorizing certified diabetes educators to provide diabetes self-management training services, including as part of telehealth services, under Part B of the Medicare program.
S. 2113, to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health; to Health, Education, Labor, & Pensions.
S. 2119, to establish a pilot program to address overweight/obesity among children from birth to age five in child care settings and to encourage parental engagement; to Health, Education, Labor, & Pensions.
S. 2516, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars.
H.R. 2276, to require the director of the U.S. Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
H.R. 2632, to amend the Internal Revenue Code of 1986 to provide incentives for life sciences research.
H.R. 2741, to amend title XVIII of the Social Security Act to reduce the occurrence of diabetes in Medicare beneficiaries by extending coverage under Medicare for medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing Type 2 diabetes.
H.R. 2787, to amend title XVIII of the Social Security Act to improve access to diabetes self-management training by authorizing certified diabetes educators to provide diabetes self-management training services, including as part of telehealth services, under Part B of the Medicare program.
H.R. 2799, to amend the Public Health Service Act to authorize grants to provide treatment for diabetes in minority communities.
H.R. 4604, to amend the Public Health Service Act to provide for a national program to conduct and support activities toward the goal of significantly reducing the number of cases of overweight and obesity among individuals in the United States.

S. 248, to allow an earlier start for state health care coverage innovation waivers under the Patient Protection and Affordable Care Act; to Health, Education, Labor, & Pensions. S. 1410, to amend the Internal Revenue Code of 1986 to provide incentives for life sciences research.
S. 1468, to amend title XVIII of the Social Security Act to improve access to diabetes self-management training by authorizing certified diabetes educators to provide diabetes self-management training services, including as part of telehealth services, under Part B of the Medicare program.
S. 2113, to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health; to Health, Education, Labor, & Pensions.
S. 2119, to establish a pilot program to address overweight/obesity among children from birth to age five in child care settings and to encourage parental engagement; to Health, Education, Labor, & Pensions.
S. 2516, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars.
H.R. 2276, to require the director of the U.S. Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
H.R. 2632, to amend the Internal Revenue Code of 1986 to provide incentives for life sciences research.
H.R. 2741, to amend title XVIII of the Social Security Act to reduce the occurrence of diabetes in Medicare beneficiaries by extending coverage under Medicare for medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing Type 2 diabetes.
H.R. 2787, to amend title XVIII of the Social Security Act to improve access to diabetes self-management training by authorizing certified diabetes educators to provide diabetes self-management training services, including as part of telehealth services, under Part B of the Medicare program.
H.R. 2799, to amend the Public Health Service Act to authorize grants to provide treatment for diabetes in minority communities.
H.R. 4604, to amend the Public Health Service Act to provide for a national program to conduct and support activities toward the goal of significantly reducing the number of cases of overweight and obesity among individuals in the United States.